reCAPTCHA Bot Shield Active Verifying human reader & generating high-resolution document...
Verifying Document Integrity15s remaining
Protected by Google reCAPTCHA v3.•Privacy•Terms Key Findings in This Report
• SilMA@Lipo-Rg3 hydrogel exhibited sustained release of ginsenoside Rg3 for over 14 days.
• The composite hydrogel showed good cytocompatibility and supported cell viability.
• SilMA@Lipo-Rg3 hydrogel significantly upregulated chondrogenic markers (COL2A1, SOX9, ACAN) compared to SilMA alone.
• Enhanced proteoglycan and glycosaminoglycan deposition confirmed improved chondrogenic differentiation.